查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2019165

肺功能檢測系統市場：商業機會、成長要素、產業趨勢分析及2026-2035年預測

Pulmonary Function Testing Systems Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球肺功能測試系統市場預計到 2025 年將達到 31 億美元，預計到 2035 年將以 6.9% 的複合年成長率成長至 59 億美元。

肺功能檢測系統市場-IMG1

由於慢性呼吸系統疾病盛行率不斷上升，以及政府推出鼓勵早期診斷和管理的扶持措施，市場正經歷強勁成長。肺功能檢測系統是評估肺功能、測量氣流、肺容量和氣體交換效率的重要工具。氣喘、慢性阻塞性肺病（COPD）和其他肺部疾病病例的增加，推動了醫院、診所和居家照護機構對肺功能檢測系統的應用。攜帶式設備、先進的肺計量計和整合分析軟體等技術創新，提高了診斷準確性和患者舒適度，加速了市場滲透。肺功能檢測系統在職業健康監測、工業應用和家庭呼吸照護領域的應用也不斷擴展。對數位健康、遠端監測功能以及緊湊易用設備整合的需求日益成長，正在加速肺功能檢測系統市場的擴張，尤其是在重視預防醫學和遠端醫療解決方案的地區。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 31億美元
預測金額 59億美元
複合年成長率 6.9%

預計到2025年，手持式肺功能檢測市場規模將達18億美元。這些攜帶式設備因其設計緊湊、價格實惠且易於使用而備受青睞，是臨床和家庭監測的理想選擇。手持式肺功能檢測系統使醫護人員和患者能夠在各種環境下進行檢測，從而提高了柔軟性和便利性。這些設備的具成本效益正推動其在小規模診所、基層醫療中心和資源匱乏地區廣泛應用。便利性、便攜性和使用者友善性的完美結合，使手持式肺功能檢測市場能夠滿足臨床和個人健康監測的雙重需求，從而保持其市場主導地位。

預計到2025年，肺功能儀市場規模將達到14億美元，並在2035年之前以7.2%的複合年成長率成長。肺功能儀仍然是評估肺功能和檢測呼吸系統疾病（例如氣道阻塞和氣流障礙）的重要診斷測試。數位介面、無線連接以及與健康數據平台整合等技術進步，使現代肺計量計更加精準、直覺和便攜。這些改進提高了患者依從性，並提升了臨床和居家照護環境中的操作效率，從而促進了其更廣泛的應用。隨著對精準、快速且易於使用的肺功能評估的需求不斷成長，肺功能儀系統預計將繼續成為市場的主要收入來源。

美國肺功能檢測系統市場預計到2025年將達到14億美元，並在2026年至2035年間以5.8%的複合年成長率成長。北美在醫療技術創新領域的主導地位推動了先進肺功能檢測系統（包括具備無線連接功能的數位攜帶式設備）的快速普及。醫療服務提供者正增加對精準、有效率且便於患者使用的診斷工具的投資。不斷成長的醫療支出，以及強調品質和早期檢測的法規結構，進一步刺激了對肺功能檢測解決方案的需求。美國市場受惠於多種因素的共同作用，包括先進的基礎設施、人們對呼吸系統健康的日益重視，以及慢性肺病盛行率的上升——而慢性肺病正是全球市場成長的主要驅動力。

目錄

第1章：調查方法

  • 研究途徑
  • 品質改進計劃
    • GMI人工智慧政策和資料完整性計劃
      • 資訊來源一致性協議
  • 調查過程和可靠性評分
    • 調查過程的組成部分
    • 評分組成部分
  • 數據收集
    • 主要來源部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估算和計算方法
    • 每種方法中基準年的計算
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測的數學影響
  • 關於調查透明度的補充信息
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 影響產業的因素
    • 促進因素
      • 慢性呼吸系統疾病盛行率增加
      • 技術進步
      • 有利的政府舉措
    • 產業潛在風險與挑戰
      • 嚴格的法規結構
      • 肺功能測試設備高成本
    • 市場機遇
      • 攜帶式和無線PFT設備的擴展
  • 成長潛力分析
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
  • 技術趨勢（基於初步調查）
    • 當前技術趨勢
    • 新興技術
  • 未來市場趨勢（基於初步研究）
  • 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
  • 專利分析
  • 價格分析（2025 年）（基於初步調查）
  • 客戶洞察
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
    • LAMEA
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 新產品類型發布
    • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

  • 手持式
  • 桌面型

第6章 市場估計與預測：依測試類型分類，2022-2035年

  • 肺功能測定
  • 運動壓力測試
  • 肺容量測試
  • 高空模擬試驗
  • 氣體擴散試驗
  • 其他類型的測試

第7章 市場估計與預測：依應用領域分類，2022-2035年

  • 慢性阻塞性肺病
  • 氣喘
  • 慢性呼吸困難
  • 肺纖維化
  • 其他用途

第8章 市場估算與預測：依最終用途分類，2022-2035年

  • 醫院和診所
  • 診斷中心
  • 居家醫療環境
  • 其他最終用戶

第9章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Baxter
  • CHEST MI
  • COSMED
  • ECO MEDICS
  • FUKUDA SANGYO
  • GANSHORN SCHILLER GROUP
  • Geratherm Respiratory
  • 歐洲醫療設備
  • MGC DIAGNOSTICS
  • MINATO MEDICAL SCIENCE
  • MORGAN
  • ndd Medical Technologies
  • PHILIPS
  • Vitalograph
  • Vyaire MEDICAL
簡介目錄
Product Code: 5722

The Global Pulmonary Function Testing Systems Market was valued at USD 3.1 billion in 2025 and is estimated to grow at a CAGR of 6.9% to reach USD 5.9 billion by 2035.

Pulmonary Function Testing Systems Market - IMG1

The market is experiencing robust growth due to the rising prevalence of chronic respiratory conditions and supportive government initiatives that promote early diagnosis and management. Pulmonary function testing systems are critical tools for assessing lung performance, measuring airflow, lung volumes, and gas exchange efficiency. Increasing cases of respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders, are driving adoption across hospitals, clinics, and home care settings. Innovations, including portable devices, advanced spirometers, and integrated analytical software, are enhancing diagnostic accuracy and patient comfort while promoting widespread acceptance. The industry is also witnessing growing use in occupational health monitoring, industrial applications, and home-based respiratory care. Digital health integration, remote monitoring capabilities, and the rising demand for compact, easy-to-use devices are accelerating the expansion of the pulmonary function testing systems market, particularly in regions emphasizing preventive healthcare and telemedicine solutions.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$3.1 Billion
Forecast Value$5.9 Billion
CAGR6.9%

The handheld segment reached USD 1.8 billion in 2025. These portable devices are favored for their compact design, affordability, and ease of use, making them ideal for point-of-care and home-based monitoring. Handheld pulmonary function testing systems allow healthcare providers and patients to conduct assessments across diverse environments, promoting flexibility and convenience. The devices' cost-effectiveness enhances their adoption in small clinics, primary care centers, and resource-limited settings. The combination of accessibility, portability, and user-friendly features ensures that the handheld segment maintains its dominance, catering to both clinical and personal health monitoring needs.

The spirometry segment accounted for USD 1.4 billion in 2025 and is expected to grow at a CAGR of 7.2% through 2035. Spirometry remains a cornerstone diagnostic test for assessing lung function and detecting respiratory issues, such as airway obstruction and impaired airflow. Technological advancements, including digital interfaces, wireless connectivity, and integration with health data platforms, have made modern spirometers more precise, intuitive, and portable. These enhancements increase patient compliance and operational efficiency in clinical and home care environments, supporting wider adoption. As the demand for accurate, rapid, and user-friendly pulmonary assessments rises, spirometry systems are anticipated to remain a primary revenue contributor within the market.

U.S. Pulmonary Function Testing Systems Market captured USD 1.4 billion in 2025 and is projected to grow at a CAGR of 5.8% from 2026 to 2035. North America's leadership in medical technology innovation supports the rapid adoption of advanced pulmonary function testing systems, including digital and portable devices with wireless connectivity. Healthcare providers are increasingly investing in accurate, efficient, and patient-friendly diagnostic tools. Rising healthcare expenditure, coupled with regulatory frameworks emphasizing quality and early detection, further stimulates demand for pulmonary testing solutions. The U.S. market benefits from a combination of advanced infrastructure, high awareness of respiratory health, and increasing prevalence of chronic lung conditions, making it a key driver of global market growth.

Prominent players in the Global Pulmonary Function Testing Systems Market include Baxter, CHEST M.I, COSMED, ECO MEDICS, FUKUDA SANGYO, GANSHORN SCHILLER GROUP, Geratherm Respiratory, Medical Equipment Europe, MGC DIAGNOSTICS, MINATO MEDICAL SCIENCE, MORGAN, ndd Medical Technologies, PHILIPS, Vitalograph, and Vyaire MEDICAL. Key strategies adopted by companies in the Global Pulmonary Function Testing Systems Market focus on innovation, technological integration, and global expansion to strengthen market presence. Businesses are investing in R&D to develop portable, digital, and connected devices that enhance usability, accuracy, and patient engagement. Strategic partnerships, acquisitions, and collaborations are enabling access to new markets, advanced technologies, and manufacturing capabilities. Companies are also emphasizing customized solutions tailored for hospitals, clinics, and home-based monitoring to meet diverse consumer needs. Expanding distribution networks, enhancing customer support, and maintaining compliance with regulatory standards are critical tactics to improve brand trust and penetration. Additionally, firms are leveraging digital platforms to offer remote monitoring, data analytics, and telehealth solutions, ensuring a stronger foothold and competitive advantage in the market.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Test type trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increase in prevalence of chronic respiratory diseases
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Favourable government initiatives
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Stringent regulatory framework
      • 3.2.2.2 High cost associated with pulmonary function testing devices
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of portable & wireless PFT devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape (Driven by Primary Research)
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Future market trends (Driven by Primary Research)
  • 3.7 Impact of AI and Generative AI on the Market (Driven by Primary Research)
  • 3.8 Patent analysis
  • 3.9 Pricing analysis, 2025 (Driven by Primary Research)
  • 3.10 Customer insights
  • 3.11 Porter's analysis
  • 3.12 PESTEL analysis
  • 3.13 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
    • 4.3.5 LAMEA
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product type launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Handheld
  • 5.3 Tabletop

Chapter 6 Market Estimates and Forecast, By Test Type, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Spirometry
  • 6.3 Exercise stress test
  • 6.4 Lung volume test
  • 6.5 High altitude simulation testing
  • 6.6 Gas diffusion test
  • 6.7 Other test types

Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Chronic obstructive pulmonary disease
  • 7.3 Asthma
  • 7.4 Chronic shortness of breath
  • 7.5 Pulmonary fibrosis
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals & clinics
  • 8.3 Diagnostic centers
  • 8.4 Homecare settings
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Baxter
  • 10.2 CHEST M.I
  • 10.3 COSMED
  • 10.4 ECO MEDICS
  • 10.5 FUKUDA SANGYO
  • 10.6 GANSHORN SCHILLER GROUP
  • 10.7 Geratherm Respiratory
  • 10.8 medical equipment Europe
  • 10.9 MGC DIAGNOSTICS
  • 10.10 MINATO MEDICAL SCIENCE
  • 10.11 MORGAN
  • 10.12 ndd Medical Technologies
  • 10.13 PHILIPS
  • 10.14 Vitalograph
  • 10.15 Vyaire MEDICAL